[go: up one dir, main page]

McRae et al., 2014 - Google Patents

Evaluation of Peripheral Blood CD4+ CD25+/-CD39+/-T Cell Populations in Patients With Renal Failure and During Acute Allograft Rejection.: Abstract# 2909

McRae et al., 2014

Document ID
11889498166453425738
Author
McRae J
Hill P
Chia J
Dwyer K
Publication year
Publication venue
Transplantation

External Links

Snippet

141 Abstract# 2906 Abstract# 2907 Abstract# 2908 Abstract# 2909 Page 1 141 Nested qPCR of laser capture-microdissected ICOS+ Tfh cells (N=40 to 60) from a subset of biopsies with MR versus TCMR revealed an approximately 800-fold and 100-fold increase for bcl6 and IL-21 …
Continue reading at journals.lww.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment; Prognosis

Similar Documents

Publication Publication Date Title
Spivey et al. Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
Gutman et al. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit
Sabbione et al. Neutrophils suppress γδ T‐cell function
Picarda et al. Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells
Mathews et al. Belatacept-resistant rejection is associated with CD28+ memory CD8 T cells
Elmaagacli et al. Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia
Wei et al. Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice
Kildey et al. Specialized roles of human natural killer cell subsets in kidney transplant rejection
Kellner et al. Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
AshokKumar et al. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation
Burroughs et al. Success of allogeneic marrow transplantation for children with severe aplastic anaemia
Dugast et al. Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients
US20140369955A1 (en) Methods for autologous stem cell transplantation
Ashokkumar et al. Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection
Braza et al. Gene expression signature in transplantation tolerance
Girmanova et al. Circulating biomarkers of tolerance
US20230039835A1 (en) Lymphocyte and monocyte populations in cancer patients and autologous stem cell preparations, and uses thereof
Dujardin et al. Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypes
Jose et al. Leptin receptor q223r polymorphism influences neutrophil mobilization after Clostridium difficile infection
KR101829997B1 (en) Kit for organ transplant rejection or monitor the status of immune rejection
Cristelli et al. De Novo Everolimus (EVR) Versus Mycophenolate (MPA) in Kidney Transplant Recipients Receiving Tacrolimus (TAC).: Abstract# 2908
Espinosa et al. CD57+ CD4 T Cells and Belatacept Resistant Rejection.: Abstract# 2906
US20190086415A1 (en) Treating patients based on immune subtypes
Tang et al. Kidney Rejection in HIV-Positive Recipients Is Associated With Immune Activation and Higher Frequency of Donor-Reactive CD8 Cells.: Abstract# 2907
McRae et al. Evaluation of Peripheral Blood CD4+ CD25+/-CD39+/-T Cell Populations in Patients With Renal Failure and During Acute Allograft Rejection.: Abstract# 2909